' -W, XY Z[EY_ 12d,\]^ M ^ μmol/L,M ^ μmol/L,! 0 \_`, a b \]! 6 c, /, & HI ( S ),- " E J_1 SU, > 1, - HI.,O

Size: px

Start display at page:

Download "' -W, XY Z[EY_ 12d,\]^ M ^ μmol/L,M ^ μmol/L,! 0 \_`, a b \]! 6 c, /, & HI ( S ),- " E J_1 SU, > 1, - HI.,O"

回贡
7 years ago
Views:

1 MedicalJournalofPekingUnionMedicalColegeHospital 1, 2 1 2, !:"#$ %&: ,E mail:lixiaoqing @126 com!" ' ; ; ()*+,-./0 #$%&' R394;R596 2 B (' (2016) DOI: /j isn ' ,+89,:0,0;,34 ' 7< =>?,@ CT ABC+DE D F GHI,' J,KL MNO, 0 P PEQ JRSTUV0W,XY! Z [T\ ]M ^E0_, `abc, UV>?2./0!0 56, J ; -./,, UV>?2 ()*+,-./0 W 02, 0,,7, 34 Y_ 23 )*+!,,45,W 3, ' , ! U W 6,, \ ES, > ! U W 6, \, ',, S () /L,, () 0 70, 94g/L, /L; [T 185U/L, 326U/L, 113U/L,, 306U/L,M ^ μmol/L,M ^ μmol/L,MN 45 9μmol/L; U ng/ml, 69 48ng/ml,Ⅳ ng/ml,Ⅲ - N! 30 15ng/ml "# $%& ', 5," ; & (, )*, (+ 66mm) KL' -W,,-. Y_/,! 0_1) SU, > () /L,, () 0 90, 111g/L, /L; [T 162U/L, 261U/L, 1017U/L,, 348 U/L, M ^ 263 μmol/l, M ^ 220μmol/L;EB0 (Epstein Barvirus,EBV) IgM ( ) 0 (cytomegalovirus,cmv) IgM (-); (-);Z [T ; 67P 89: : ; : - 2 (-); & 3 < =>?@ AB, C U AB, A ; ADABC+D& A, ES D, C AB; & 3 F KL -G,MN, H,- IJ KLJ MEY_.,!_1) SU,M ^,N] K M ^ 327 5μmol/L,M ^ 268 9μmol/L, O > G K (-); 6 7 P (-); EBV IgM (+) EBV DNA (+) CMV IgM (+); 7Q : 9 DNA: : SM : : SSA/SSB: : SCL 70: : Jo 1: (-), : Ro 52: (+);PQ (-) R,N]O 48 5μmol/L KL2 0 5,-STUV W 392 September,2016

2 ' -W, XY Z[EY_ 12d,\]^ M ^ μmol/L,M ^ μmol/L,! 0 \_`, a b \]! 6 c, /, & HI ( S ),- " E J_1 SU, > 1, - HI.,O ! K, R ]? 1 >\]! A, &,R ' U 60ml,$% c 1 012, () /L, () /L, ( ) /L, () /L, (-) KLSFG0 5,-STUV 0 25g 12 1 C Y_. ',M ^ / M 300/240μmol/L<= 2 > 1! G0, ; \,, 3~4 1, 2 1H, ' c 15kg./-01 -! 8: 6 J E, E, P PE, 0, 76 /min, 125/76mmHg(1mmHg= 0 133kPa),2, U ', _, b, E+ 3, 6,, (+); E+ 6,, (-),,1 /min V- ;,, 0 0 Y 23! J () /L,, ( ) 0 91, ( ) /L, 88g/L, (28~32) 10 9 /L, ( ) 0 03 * 3 5 mmol/l, 32g/L, / 1 6, 156U/L, 347U/L, 479U/L,, 196U/L,M ^ 357 1μmol/L, M ^266 4μmol/L,MN 126 4μmol/L, ^ 1 84 mmol/l,j 4 72mmol/L, 24μmol/L, 106 7μmol/L +:ph 7 0,M ^, M- 3 2μmol/L + :',, (-) Z Z - ] 14 6s, 1 31, g/L, Z ] 33 6s,D! 0 57mg/L FEU "# :Z - ] Z ] $%#,2hJST# &' : 21 ^ 36 74mU/L, nmol/L, pmol/L,: 2 1 P : 36 72U/ml ' :( 4 ( 8 93μmol/L,( $) 37 73μmol/L,( 30μg/L, ( * %, 3 8ng/ml %-. M /0%- (-) β mg/L %. () SE,, %. () 2 (); _,%. 1%34(), 5 ' :Ig+6 : : 7 19 :, ())": :8 : 9 : : 7 : gp210:.; 6Q :2 25 1μg/L,89: kU/L,89: kU/L 5 : : 25~38mm/h; C 33 09~54 30 mg/l;cmv IgM (+),CMV DNA CMV pp65 EBV DNA (-),EBV5 : :- IgG :- IgG (+), (-) ^- 0 60ng/ml TB()9 :T B()U (B() 35/μl,T () 241/μl,CD4+T() 112/μl);CD8+T() ; $ 5 T()<= (-),$ > ^ (-) 5 (-) P : cbc PQ (-) D : 5 $ (D E ). ;? C C ' C A ; F +U A, F +A C C 3 '.U ; &, 7 1cm,+ 3 3cm, A 1 5cm,,+ 6 4cm;,F) ] ;, $SF G & 3 AG,b+3 HS,< I J K [ T, 70% Vol 7No 5 393

3 L AD CT+?b =,< Mc ( 1A),< GMc, L N AG, *O; A, + ( 1B), C C? A,M AG, M < 15, ABC M?b &, C C A,. GM? 0 &,?PQ,SR0 %SG? D / TUV +D (positronemisiontomography/compu tedtomography,pet/ct) E A, +,WX (,A], 7Y 2 2, 7Y 3 0; EA,WXaA], 7 Y 1 4, 7Y 1 9;,ST F ',0*; C A,K L G, ) * % T;=,, < < Mc,WXaA],KL,0*, : JZ[;= \] $,WXaA],KL,0* ( 2) "# : F,? (LA A),', 5, " ] "?0^:" ', _>: _>]+`a bc,0* ( 6%T), $, abc 5 _ > K L b c, 0 * % T, $ 6 S F G! 5 6 CMV EBV5, G_>, %T UV>? _>KL$ >5 S, 0*-WSU,,0*%T, ; 4 % >?# G_> KL! Z [T;,S ) # ; SKL,.! J- - IJ 1 2g 1 /dc M 1g 1 /dc M 250mg 3 /d '., 20mg/d 40mg/d 9 11 ;J 100mg 1 /dc,!m ^,N],M ^ /M 400/ 300μmol/L<= $) _>., D> J :!7 D $ 1 L AD CT A =,< Mc ( W);B A, + $ 2 %SG? D /TUV +D E A, +,, (A], 7Y 2 2, 7 Y 3 0; EA,, aa], 7Y 1 4, 7Y 1 9, C A 394 September,2016

4 ' -W, CT%. EU A, + (, U ; 70 %.,,&, EU A AD CT%. 2 D,.; 0 ; C 3 U A, <>6,M U AG, D?c %.,.UV A E56 G EADA BC+D%. ED S 56, SF) C H,W C H 7 E 567S D S (, 1! EL, =,7; KL1! D)*Y 0>? &, ' A %T EA C ' FA :, ( )*%T EWX; : ; 6 9:!8,,99,:0, 34562, c7',, G $, c U,, E56, I & ', M? N],M ^ M ^ N]23, D& U, ]WX, 0 EBV IgM CMV IgM (+)!, N],M ^N] M ^ 23, 4KLHI,', CT ABC M?b & M?,FG GHI,KL MNO.7 : MNO 70W (),MNO M?(),MNO, (),M NO. _ ^ _ 0,,, WX, 0 6 / *Ebc,0* $ 1 *,A* ) C H O E;M?(),MNO. -G,MN, H -G,H,M? ), 7c ) IgG4:,M? P,M?0 M _ GH,M? G,+ M? _ P: 30E! + MNO 70W,KL:(1) 5 :0 EBV IgM (+),EBV DNAb + N ],CMV IgM (+), 0,:0 J [TR,,ST 0;;$ 5 LX,! < M c E b c, ) *, $ _1,$ >^ $ 5 T( )<= (-),$ S (2) ' 0:!, E (,WXA], )*,0;, U, G $ 0^, F 6;! Ebc,)*, 4KL *,! E E 5 6, M, "()A P 70^:, F (3) 6:Y (, ;,! U, 67P 2 GP73 (-), ;70^, >? (4) ' 0: -G,MN, H -G,H,M?, IgG4:,M?,!: 7,, S (5) : P P?0 ( ) C H O ) 0 M? ), 0^!>?, 70^,! Z [T\ OM c, `], 0^ %T2,,.? < 6=>?9:!8,,0 3, MNO U A c, UV _1 LX 5 : 734 G CMV IgM EBV IgM (+),G EBV DNAR + (+);T()9 &!() [TU,CD8+T() U ;Q Ig0 1!0,, R ' 5 6, 5 ]+,! [T; K %T,!Q (-), 70, () 256, E N] M ^N]S2U, = 1!SF, KL% F G KL %T, CMV CMV IgM,, 1 G CMV DNA (-),!0 G $ E56, STUV %SU,1 CMV IgM, +,K LSFG 0 5,%T, KL CMV 5 %T, EBV5 LX, EBV5 2, ()A _,1!%FG 0 %. ',, EBV5,! G $,% 64 () ), G ' A!, 0, 6E,1!G R EBV IgM EBV DNA,, U Vol 7No 5 395

5 , _ 7 ( C ) U N], %. 1%34(), STFG', EBV5 %T,KL% 0^ EBV- " UV LX, 5 ]+<= - W, FG$ > #$%-A (&>5 E, 1!,0 G &>5 : &,.#$%-AE,KLJ!%T, $ >5 LX, $ $ >5 5 6, $ ' E 1!.$ >5 56, $ 5 T()<= (-), 2S> = 4UV E$ >? 4 0^,%. ( ) *56 1!ST FG$ > 5, E0^, UV 1! PET/CT, 562 EU A WX,; A],, C U A %. $, WX,S];, %.b+, ;= G<,+??,,! A WX, (,A]% LX KL:(1)5,0*:4 0 ;(2) ' 0: bc, 6! PET/CT WX, U A], 1! E7Y b+a ],SFG-, 6bc%T UV DE 6 9:! 8,, ,, E2OM,)*,M ^U N], KL bc,0* 0]+, 2,0* K L 6, 656, G $,PET/CT%.0 7Y U N],.7~8, ]%. 10~20<= = 1!SF, ST 2FG 1! 5 / 1cm 1cm<= 0 $,,`, 6bc7 $56 W! >? 0: 8M, R ]+` a 6 F 6,0*G, bc, 0 KL * WX:, ^ >,! U V, &, 6: 9:!8,, 562 ', D& (,bc0*! c 0^,0^$% : # %. ' P, # %. ' P () ()]71 M? 4())" ] # %. () *, *,,= 1 *; )" %. ' 2 P %.1M3 4? %.5@ ()bc, +6 ()2 3 %.A* M?,.M3 ]+` a 6, :,@ ( )bc U 7 4?,CD3 CD20 (+),7U 8 bc7 ()29(),S > 6 >?! 0 ^ O M , $)1! =,KL2 (),', 0W 0 5 ()WX, 0, 4 <=7 0. / 0, 1! ( ) ) " 1M? ' 2 P@ 1# %. :, %. Matlese; $, 2./ 0 ;56 KL1!0^>?./0:YU V, % $) $% ; 6 9:! 0^>?UV, 7 :,KL./0UV ( 0,! 3 : 6U 7,562 15~20min 6, $,+8J.<, 1_1SU,! () -./ 113 1μg/g Hb( 0~4 7μg/gHb),./.M- 2 (-); >?KL ()*+,-./0 ; 6 FGH , >? 6 7 =>! >?:YUV,$)./.M-,, -./U N]56,F) ()*+,-./0 EBV5, () [T U, ^ OM ], SV0, AB CD! C",0; G,% M ^ E )! _1 7,% _> IJ '.7_1, 396 September,2016

6 ' -W, 0 +!@FG GHIJ, c KL >? G(570 (!7 ) ( )*) _ *& S 7>?=>./0. 0,F ' 2 G567S,@GJ7 H,Y SU-W' G 0*!, K L 0%T K L _>JKL% M ^ E, M ^ EJ, M ^ /M ^ 430/333μmol/L O 256/208μmol/L,\ J N O 400/300μmol/L KL S 1!, \, : I %7 JJK 300mg/d,O 9 28 K M ^ * S! 4L! J,M 100μmol/L<= M8J! >Z>, ; N%, 1TO *;! W,G W FECH WG S 87 ; ) * [CGA TGA,Arg298Ter(C/T ))], ()*+,-./07 >? >?: ()*+,-./0 ( \: ) 櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒櫒 M J NO 6! ( 2 ) KeyNotesOnPlasticSurgery(2nded.)(2015) 3 :AdrianRichards,HywelDafydd :Wiley 整形外科的业务范围较广, 不但有大众熟知的美容外科, 还有大量的修复重建工作, 而且很多不仅仅是医学问题, 还与伦理和法律有密切联系本书的两位主编来自英国, 而撰写前言的专家是台湾长庚医院的魏福全教授, 该院整形显微外科在世界享有盛誉本书名为笔记, 实际上主要以文字介绍整形外科的内容全书分为 10 部分第 1 部分为总论, 包括皮肤胚胎学, 皮肤结构和功能, 皮肤的血供, 皮瓣分类, 创面愈合, 植皮, 骨软骨神经移植物, 组织工程, 缝线敷料, 组织扩张, 局部麻醉, 显微外科以及止血等第 2~7 部分按照器官系统介绍整形外科的专业知识, 如皮肤软组织疾病头颈部乳房和胸壁上肢下肢躯干和泌尿生殖系统等第 8~ 10 部分分别是烧伤美容外科, 伦理法律和统计学知识本书名为关键笔记, 书中内容均为干货, 省略了不必要的枝蔓例如在乳房章节, 简要概括乳房的解剖血供神经表解剖, 还对女性内衣的罩杯进行描述 ; 随后对缩乳术的历史发展进行概述, 以及对各种手术技术的优缺点进行对比本书主要适合整形外科医生, 特别是整形外科住院医生阅读 ( G 'PQ) ( RS ) Vol 7No 5 397

GON GYI ZHIZUO ( ) 105 100037 68418523 ( ) 68982468 ( ) mail.cnu.edu.cn 2006 6 1 2006 6 1 787mm 1 092mm 1/ 16 ISBN 7-810

GON GYI ZHIZUO ( ) 105 100037 68418523 ( ) 68982468 ( ) www.cnup.cnu.cn E-mail cnup @ mail.cnu.edu.cn 2006 6 1 2006 6 1 787mm 1 092mm 1/ 16 ISBN 7-81064-573-0 /G64 5 110 3. 10 ,, :,,, ;,,,,,,,, 2 1 4 1,,,,,,,,,,,,